Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
JSPRW | Jasper Therapeutics Inc | 0.30 | 0.15 | 100.00% | 100 |
NUKK | Nukkleus Inc | 29.50 | 8.97 | 43.69% | 1,821,806 |
VS | Versus Systems Inc | 2.5601 | 0.6401 | 33.34% | 3,115,978 |
ISPC | iSpecimen Inc | 3.40 | 0.55 | 19.30% | 2,948,868 |
TGL | Treasure Global Inc | 0.2479 | 0.0336 | 15.68% | 3,870,951 |
TMC | TMC the Metals Company Inc | 1.78 | 0.21 | 13.38% | 642,217 |
HUBCW | Hub Cyber Security Ltd | 0.0399 | 0.0045 | 12.71% | 200 |
HUBC | Hub Cyber Security Ltd | 0.7399 | 0.0833 | 12.69% | 144,899 |
ENVB | Enveric Biosciences Inc | 0.394 | 0.0439 | 12.54% | 7,621,568 |
HKPD | Hong Kong Pharma Digital Technology Holdings Ltd | 2.9918 | 0.3018 | 11.22% | 11,372 |
ICON | Icon Energy Corporation | 2.35 | 0.2366 | 11.20% | 1,323 |
NEW YORK, Jan. 16, 2025 /PRNewswire/ -- Nukkleus, Inc. ("Nukkleus" or the "Company") (NASDAQ: NUKK) announced today that it has been notified on Jan.15, 2025 that it has regained compliance with the market value of listed securities requirement as outlined in Nasdaq Listing Rule 5450(b)(2)(A) and the market value of publicly held shares requirement as outlined in Nasdaq Listing Rule 5450(b)(2&3)(C).
QT Imaging Holdings, Inc. (NASDAQ:QTI) (“QTI”) a medical device company engaged in research, development, and commercialization of innovative body imaging systems is pleased to announce the release of a machine learning-enabled image interpolation algorithm designed to significantly reduce scan times by approximately 50%. This advancement is expected to enhance patient comfort by decreasing time spent on the scanner and improve operational efficiency by increasing the number of patients scanned within a given timeframe.
The aggregate gross proceeds from the Offering were $5,614,740, before deducting underwriting discounts and other related expenses, including $4,000,000 received by the Company and $1,614,740 received by the selling shareholders of the Company. In addition, the Company has granted the underwriters a 45-day option to purchase up to 150,000 Ordinary Shares to cover over-allotments at the initial public offering price, less underwriting discounts. The Company intends to use the net proceeds for the development and upgrade of its supply chain enterprise resource planning systems; to fund the procurement of warehouse equipment to improve efficiency; to fund the expansion of its ...
This next phase of construction marks an exciting continuation of the Company's efforts to develop affordable and sustainable housing in the South Texas region. Building on the success of the initial five homes in the Sugar Developments, which are already listed for sale, the Sugar Developments aim to further enhance the community and expand the availability of high-quality single-family homes.
Rank | Ticker | Board Name | Posts (24h) |
---|---|---|---|
RDGL | Vivos Inc | 48 | |
ELTP | Elite Pharmaceuticals Inc | 47 | |
COOP | Mr Cooper Group Inc | 52 | |
4 | XRPUSD | Ripple | 51 |
5 | RNVA | Rennova Health Inc | 27 |
6 | PHIL | PHI Group Inc | 24 |
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 100,132.49 | 122.48 | 0.12% | 1.98T | 5,742,641,454 |
ETH | Ethereum | 3,310.03 | 3.36 | 0.10% | 398.02B | 3,015,511,928 |
XRP | Ripple | 3.27 | 0.030 | 0.93% | 183.27B | 7,705,900,434 |
USDT | Tether USD | 0.99992 | 0.00011 | 0.01% | 119.63B | 539,926,556 |
BNB | Binance Coin | 709.72 | 1.75 | 0.25% | 111.83B | 233,448,190 |
SOL | Solana | 210.75 | -0.360 | -0.17% | 98.9B | 2,049,546,078 |
DOGE | Dogecoin | 0.37665 | 0.00035 | 0.09% | 55.01B | 1,530,443,119 |
ADA | Cardano | 1.09 | 0.00 | 0.00% | 38.91B | 724,740,128 |
USDC | USD Coin | 1.00 | 0.0001 | 0.01% | 35.55B | 1,277,694,711 |
STETH | stETH | 3,310.10 | 5.42 | 0.16% | 32.43B | 4,180,110 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions